Case Report: Efficacy of Reduced Doses of Asfotase Alfa Replacement Therapy in an Infant With Hypophosphatasia Who Lacked Severe Clinical Symptoms

Denise Goodbar January 27, 2021

0 Comments

To read more please click on the link below.
Read Article

Categories: Scientific Publications

Tags: asphotase alpha, dose, enzyme replacement therapy, low-alkaline phosphatase, lower dose, Strensiq

Blynda’s Journey with HPP

When I was born in 1968, my parents assumed everything was fine. They took me home and being her 1st child, my mom thought everything…

Taralyn Naslonski November 6, 2020

0 Comments

Patients of the Month- Amy and Suzanne

Hi, we are twin sisters Amy and Suzanne, we have been dealing with symptoms of HPP for a lifetime. Our diagnosis seemed as though it…

wpengine June 8, 2022

0 Comments

Five-Year Efficacy and Safety of Asfotase Alfa Therapy for Adults and Adolescents with Hypophosphatasia

To read more please click on the link below. Read Article

softbones October 28, 2020

0 Comments

Isabella and Julia

They are identical mirror twins who overcame all odds to survive their arrival. Isabella & Julia were born at 35 weeks and 6 days. Brought…

Taralyn Naslonski November 6, 2020

0 Comments

Living with HPP- Nele

My name is Nele from Belgium and I have hypophosphatasia. The first time I heard about HPP the look on my face was at about…

Taralyn Naslonski January 18, 2021

0 Comments

Responses

You must be logged in to post a comment.

Mail Address
The US Hypophosphatasia Foundation
141 Hawkins Place, #267
Boonton, NJ 07005, USA.

Organization

Programs

Community

Office Address
1719 NJ-10, Suite 315
Parsippany, NJ 07054

Follow Us on Social Media!

Disclaimer: This Website is owned by Soft Bones, Inc. All materials contained in this Website (the “Materials”) are either owned by or licensed to us and are protected by intellectual property and other laws. We retain all proprietary rights to the Materials. This Website is copyrighted. All rights are reserved. Except as expressly authorized by us, any use, copy, reproduction, display, performance, modification or retransmission of the Materials is strictly prohibited.

Related Articles

Responses